We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CVS Health Corporation | NYSE:CVS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.81 | 1.47% | 55.96 | 56.43 | 54.96 | 55.22 | 23,942,832 | 01:00:00 |
FORM 3
|
Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person * Hourican Kevin |
2. Date of Event Requiring Statement (MM/DD/YYYY)
|
3. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [CVS] |
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below) EVP & President, CVS Pharmacy / |
|
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned |
|||
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock | 7709 | D | |
Common Stock (restricted) | 1232 (1) | D | |
Common Stock (restricted) | 399 (2) | D | |
Common Stock (restricted) | 840 (3) | D | |
Common Stock (restricted) | 2444 (4) | D | |
Common Stock (restricted) | 2146 (5) | D | |
Common Stock (restricted) | 3523 (6) | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option | 4/1/2014 (7) | 4/1/2020 | Common Stock | 4426 | $54.53 | D | |
Stock Option | 4/1/2015 (8) | 4/1/2021 | Common Stock | 9442 | $74.29 | D | |
Stock Option | 4/1/2016 (9) | 4/1/2022 | Common Stock | 17822 | $102.26 | D | |
Stock Option | 4/1/2017 (10) | 4/1/2023 | Common Stock | 17611 | $104.82 | D | |
Stock Option | 4/3/2018 (11) | 4/3/2024 | Common Stock | 30169 | $78.05 | D | |
Stock Option | 4/1/2019 (12) | 4/1/2025 | Common Stock | 87575 | $62.21 | D |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Hourican Kevin
ONE CVS DRIVE WOONSOCKET, RI 02895 |
|
|
EVP & President, CVS Pharmacy |
|
Signatures
|
||
/s/ Kevin P. Hourican | 6/8/2018 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year CVS Health Chart |
1 Month CVS Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions